IRD FY 2023 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M-52.2% YoY

Gross Profit

$19M100.0% margin

Operating Income

-$11M-55.5% margin

Net Income

-$10M-52.4% margin

EPS (Diluted)

$-0.46

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$54M

Total Liabilities

$4M

Stockholders' Equity

$50M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$40M	-52.2%
Gross Profit	$19M	$40M	-52.2%
Operating Income	-$11M	$18M	-158.0%
Net Income	-$10M	$18M	-155.8%